Royan Institute
royaninstitute.orgTotal trials
93
Active
1
Phase 3
27
Total enrollment
6,901
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Dopacell | — | — | — | — | — | 1 | |
| Immunosuppressive Regimen | — | — | — | — | — | 1 |
Next readouts
- 2028-08-01
Top conditions
- Infertility19
- Osteoarthritis4
- Polycystic Ovary Syndrome4
- Amyotrophic Lateral Sclerosis4
- Infertility, Female3
- Ovarian Hyperstimulation Syndrome3
- Embryo Implantation2
- Hip Osteoarthritis2
Frequently asked questions about Royan Institute
- How many clinical trials does Royan Institute have on ClinicalTrials.gov?
- Royan Institute is listed as the lead sponsor on 93 clinical trials in ClinicalTrials.gov, 1 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Royan Institute's trials are in Phase 3?
- 27 of Royan Institute's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Royan Institute focus on?
- Royan Institute's most-studied conditions on ClinicalTrials.gov are Infertility, Osteoarthritis, Polycystic Ovary Syndrome, Amyotrophic Lateral Sclerosis, Infertility, Female.
- When are Royan Institute's next clinical trial readouts?
- Royan Institute has 1 upcoming primary-completion readout tracked here; the soonest is “Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's Disease”, expected around 2028-08-01.